It may activate surrounding glial cells (and secondarily GnRH) through TGFα [67] or provide indirect evidence through the presence of GnRH immunoreactivity within the tumor that indicates excess GnRH production [68]. This evidence concerns the gene GNRH1 and neoplasm.